Pancreatic cancer patients denied life-extending drug by spending watchdog
The health spending watchdog has refused to fund the pancreatic abraxane despite evidence that it can double life expectancy
Source: Telegraph Health - Category: Consumer Health News Tags: pancreatic cancer pancreas symptims nice drugs treatments funding decision Source Type: news
More News: Abraxane | Cancer | Cancer & Oncology | Funding | Health | National Institute for Health and Clinical Excelle | Pancreas | Pancreatic Cancer